相关实验视频

Updated: Jan 11, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

里图西马布诱导的急性冠状动脉综合征

Paschal O Ndukwu¹, Niharika Patlolla¹, Neharika Narayanan¹

¹Acute Medicine, United Lincolnshire NHS Hospital Trust, Boston, GBR.

|November 10, 2025

概括

在淋巴瘤和自身免疫性疾病中用于B细胞枯竭的瑞图西马布可能会导致急性冠状动脉综合征 (ACS). 这一案例凸显了在Rituximab治疗期间监测心脏健康的重要性,特别是在高危患者中.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
心脏病学心脏病学

背景情况:

利图西马布是一种单克隆抗体,向CD20+B淋巴细胞,对于治疗B细胞驱动疾病至关重要.
B细胞枯竭是治疗淋巴增殖性疾病和自身免疫性疾病的关键机制.

研究的目的:

报告一种Rituximab诱导的急性冠状动脉综合征 (ACS) 的病例.
为了强调Rituximab治疗的潜在心脏毒性作用.

主要方法:

一个老年男性的病例研究,患有脏边缘区域淋巴瘤,正在接受rituximab化疗.
使用了临床监测,心脏生物标志物评估 (热素T),心电图和计算机断层扫描 (CT) 和冠状动脉血管图.
实施了保守的管理和暂时停止rituximab治疗.

主要成果:

患者在Rituximab输注期间经历了急性胸痛,怀疑是ACS.
心脏生物标志物初步上升,但心电图没有什么显著的.
胸部疼痛在Rituximab停止后消失;CT冠状动脉血管图证实了ACS.
由于血小板缺血,患者接受了保守的治疗,并暂停了Rituximab.

结论:

利图西马布治疗可能与心脏毒性相关,呈现为ACS.
在Rituximab输注期间,对心脏事件的警至关重要,特别是在患有心血管风险因素的患者中.
这一案例强调了需要仔细选择患者和监测Rituximab治疗方案的需要.

关键词:

急性冠状动脉综合征急性冠状动脉综合征心脏胸部疼痛心脏胸部疼痛遥远的左前下降动脉 (拉德)有助于炎症的细胞因子.利图西玛布治疗方法

更多相关视频

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...